LN

Lakshmi Narayanan Lakshmi Sankar

Active Director Director DIN 10838944
DIN 10838944 First appointment Nov 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Lakshmi Narayanan Lakshmi Sankar

Data last updated:

Lakshmi Narayanan Lakshmi Sankar is a Director at Netra Lifesciences Private Limited (since 2024). The company operates in Pharma.

DIN 10838944
Primary Designation Director
Industry Pharma
First Appointment 20 Nov 2024
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Netra Lifesciences Private Limited U47721TN2023PTC163329
Director20 Nov 20242023Active

Board colleagues of Lakshmi Narayanan Lakshmi Sankar

Directorship timeline

Open interactive timeline →
Netra Lifesciences Private Limited
Premium access

Shareholding and investment profile for Lakshmi Narayanan Lakshmi Sankar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lakshmi Narayanan Lakshmi Sankar

Lakshmi Narayanan Lakshmi Sankar currently holds 1 directorship: Netra Lifesciences Private Limited (Director, since 20 Nov 2024).

Lakshmi Narayanan Lakshmi Sankar was first appointed on 20 Nov 2024 as Director at Netra Lifesciences Private Limited.

The current boards of Lakshmi Narayanan Lakshmi Sankar's companies include Gomathi (Netra Lifesciences Private Limited), Kavitha Srinivasan (Netra Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available